Skip to main content
SpringerLink
Log in

Letter to the Editor: “Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer”

  • Letter to the Editor
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 09 July 2021

The Original Article was published on 27 October 2020

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Li W, Fu M, Zhao K et al (2020) Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-020-06444-3 (Epub ahead ofprint)

    Article  PubMed  PubMed Central  Google Scholar 

  2. Scosyrev E, Glimm E (2019) Power analysis for multivariable Cox regression models. Stat Med 38:88–99

    Article  Google Scholar 

  3. Walter SD (2005) The partial area under the summary ROC curve. Stat Med 24:2025–2040

    Article  CAS  Google Scholar 

  4. Yang J, Guo X, Zhang H et al (2019) Differential diagnosis of pancreatic serous cystadenoma and mucinous cystadenoma: utility of textural features in combination with morphological characteristics. BMC Cancer 19:1223

    Article  Google Scholar 

  5. Fountzilas E, Kotoula V, Angouridakis N et al (2013) Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer. PLoS ONE 8:e70429

    Article  CAS  Google Scholar 

Download references

Acknowledgements

I am grateful to Dr. Hui-Zi Li for his professional support for the study.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Zhongshan Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine, 3 Kangxin Road, Zhongshan, 528400, Guangdong, China

    Meng-Si Luo

Authors
  1. Meng-Si Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

M-SL drafted and revised the letter.

Corresponding author

Correspondence to Meng-Si Luo.

Ethics declarations

Conflict of interest

The author declares that she has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by the author.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, MS. Letter to the Editor: “Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer”. Eur Arch Otorhinolaryngol 278, 3583–3584 (2021). https://doi.org/10.1007/s00405-020-06524-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-020-06524-4

Search

Navigation